business

Robeauté Develops Rice-Sized Microrobots for Targeted Brain Therapy

14 Ağustos 2026Bloomberg

The CEO of French neurotechnology startup Robeauté has unveiled a groundbreaking microrobot designed for targeted drug delivery directly into the brain. These microrobots, comparable in size to a grain of rice, can access previously unreachable areas with existing treatments.
Joana Cartocci announced plans for first-in-human studies by 2027 and aims for a market launch in the early 2030s.
The advancement of microrobots in medical applications represents a significant shift in how complex diseases, particularly those affecting the brain, can be treated. With traditional methods often falling short in precision and effectiveness, Robeauté's technology could pave the way for more personalized and effect…
Robeauté's innovative approach to brain disease treatment could revolutionize the way therapies are administered, potentially increasing efficacy and reducing side effects. The development of such microrobots highlights the growing intersection of technology and medicine, raising questions about regulatory pathways…

NewsAI özeti

This article is for informational purposes only and does not constitute medical advice.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.